Abstract
BackgroundBisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare, yet significant, adverse effect of bisphosphonate therapy. A multidisciplinary approach to the prevention of BRONJ is recommended due to the significant...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have